Confronting Challenges in the Management of C difficile: Recurrent Infection and Hypervirulent Strains

Get the latest data and guidance on managing initial, recurrent, and hypervirulent CDI in this program, which features an Interactive Virtual Presentation by a CDI expert plus focused commentaries.
Princy N. Kumar, MD, FIDSA, MACP

ClinicalThought

How can the risk of recurrent C difficile infection be reduced? Here are strategies that I consider in my practice.

Princy N. Kumar, MD, FIDSA, MACP Released: December 14, 2018
Provided by Postgraduate Institute for Medicine
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue